Back Hepatitis B Hepatitis B Topics HBV Populations Injection Drug Users

IAS 2013: Experts Discuss Role of Drug Policy in HIV, Hepatitis, and TB Epidemics

International drug policy must shift from prohibition to public health in order to reduce harms to individuals and societies, including fueling the spread of HIV, hepatitis, and tuberculosis, experts from a range of disciplines agreed at 2 sessions held during the 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this week in Kuala Lumpur.alt

Read more:

Naloxone Is Cost-effective Way to Prevent Heroin Overdose Deaths

Distributing naloxone more widely to heroin users would reduce the number of deaths due to overdose and would be a cost-effective intervention, according to a mathematical model described in the January 1, 2013,Annals of Internal Medicine. Providing naloxone to prescription opiate users would prevent even more deaths.

alt

Read more:

10 Million Injection Drug Users May Have Hepatitis B or C

Approximately 10 million injection drug users (IDUs) worldwide might be infected with hepatitis C virus (HCV), and more than 1 million may be living with hepatitis B, according to a meta-analysis of data from over 70 countries published in the July 28, 2011, advance online edition of The Lancet. alt

Read more: